DocMed is the technology investment and development arm of Hyphens Pharma International Limited, Singapore's leading specialty pharmaceutical and consumer healthcare group. We invest and develop digital healthtech solutions to empower various healthcare stakeholders in Singapore and the region. Our business dovetails with the Group's existing digital assets in Pan-Malayan Pharmaceuticals, namely POM, Singapore's leading online B2B medical hypermart, and WellAway, Singapore's first and only HSA-registered e-pharmacy.